Diagnamed Holdings Corp. (CSE:DMED)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
Mar 28, 2025, 3:51 PM EST

Diagnamed Holdings Statistics

Total Valuation

CSE:DMED has a market cap or net worth of CAD 2.50 million. The enterprise value is 2.39 million.

Market Cap 2.50M
Enterprise Value 2.39M

Important Dates

The next estimated earnings date is Monday, May 26, 2025.

Earnings Date May 26, 2025
Ex-Dividend Date n/a

Share Statistics

CSE:DMED has 83.41 million shares outstanding. The number of shares has increased by 1.37% in one year.

Current Share Class n/a
Shares Outstanding 83.41M
Shares Change (YoY) +1.37%
Shares Change (QoQ) +0.88%
Owned by Insiders (%) 11.93%
Owned by Institutions (%) n/a
Float 73.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.54
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.36

Current Ratio 0.36
Quick Ratio 0.35
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -411.93

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -109.64%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 214.04%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.50% in the last 52 weeks. The beta is -2.34, so CSE:DMED's price volatility has been lower than the market average.

Beta (5Y) -2.34
52-Week Price Change -12.50%
50-Day Moving Average 0.03
200-Day Moving Average 0.02
Relative Strength Index (RSI) 50.36
Average Volume (20 Days) 203,500

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -626,545
Pretax Income -674,889
Net Income -674,889
EBITDA n/a
EBIT -626,545
Earnings Per Share (EPS) -0.01
Full Income Statement

Balance Sheet

The company has 114,332 in cash and n/a in debt, giving a net cash position of 114,332 or 0.00 per share.

Cash & Cash Equivalents 114,332
Total Debt n/a
Net Cash 114,332
Net Cash Per Share 0.00
Equity (Book Value) -292,718
Book Value Per Share -0.00
Working Capital -292,718
Full Balance Sheet

Cash Flow

Operating Cash Flow -350,791
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:DMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.37%
Shareholder Yield -1.37%
Earnings Yield -26.97%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a